Completed NA INTERVENTIONAL 6-arm NCT02008097

Clinical Benefits of B-Flow Ultrasound

Evaluation of Clinical Benefits of B-Flow With the LOGIQ E9 Ultrasound System

Sponsor: General Electric

Conditions Arterial Occlusive Diseases Evidence of Liver Transplantation Hypertension Pregnancy Pregnancy, High Risk

Interventions GE LOGIQ E9 Ultrasound System

Updated 7 times since 2017 Last updated: Apr 28, 2018 Started: Oct 31, 2013 Primary completion: Aug 31, 2015 Completion: Sep 1, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02008097, this NA trial focuses on Arterial Occlusive Diseases and Evidence of Liver Transplantation and remains completed. Sponsored by General Electric, it has been updated 7 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
May 2017 — Jun 2018 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Enrolling By Invitation NA
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation NA

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Electric
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States